Drug Profile
Research programme: combination dermatology therapeutics - Dermipsor
Alternative Names: DPS-151; DPS-201Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Dermipsor
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atopic dermatitis; Skin disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Skin-disorders in Israel
- 16 Jul 2016 No recent reports of development identified for research development in Atopic-dermatitis in Israel